AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 755.00 Change Price %
High 755.90 1 Day -2.25 -0.30
Low 733.15 1 Week 1.70 0.23
Close 748.25 1 Month 93.10 14.21
Volume 2340391 1 Year -42.05 -5.32
52 Week High 895.00
52 Week Low 503.05
AUROPHARMA Important Levels
Resistance 2 769.34
Resistance 1 760.65
Pivot 745.77
Support 1 735.85
Support 2 727.16
NSE INDIA Most Active Stocks
JPASSOCIAT 26.60 15.40%
GVKPIL 10.00 19.76%
SINTEX 37.35 -1.32%
GMRINFRA 18.00 1.12%
SUZLON 19.15 3.51%
UNITECH 8.45 -1.17%
IDEA 91.95 -3.26%
IFCI 27.55 4.95%
RENUKA 19.40 17.22%
STRTECH 222.80 7.53%
More..
NSE INDIA Top Gainers Stocks
SPCENET 0.20 33.33%
TIPSINDLTD 79.20 20.00%
GVKPIL 10.00 19.76%
RENUKA 19.40 17.22%
TARAJEWELS 32.05 16.76%
NAKODA 0.35 16.67%
ARCOTECH 98.20 16.08%
SIGNET 10.65 15.76%
JPASSOCIAT 26.60 15.40%
LYKALABS 61.25 15.35%
More..
NSE INDIA Top Losers Stocks
LCCINFOTEC 0.20 -20.00%
SERVALL 2.55 -10.53%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
ANKITMETAL 1.30 -7.14%
JVLAGRO 25.05 -7.05%
DISHTV 78.10 -6.02%
NUCLEUS 289.55 -5.90%
COUNCODOS 4.00 -5.88%
RSSOFTWARE 78.95 -5.56%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 21st Jul 2017 AUROPHARMA Share Price closed @ 748.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 702.30 & Strong Buy for SHORT-TERM with Stoploss of 637.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for July
1st Target up-side 751.31
2nd Target up-side 798.06
3rd Target up-side 844.82
1st Target down-side 617.89
2nd Target down-side 571.14
3rd Target down-side 524.38
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 67.93 Sideways
MFI (14) MFI is 67.12 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -37.10 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 721.64
10 Day Avg Volume Traded -39.93 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.